Abreha T, Hwang J, Thriemer K, Tadesse Y, Girma S, Melaku Z, et al. Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial. PLoS Med 2017;14(5):e1002299. https://www.ncbi.nlm.nih.gov/pubmed/28510573
Amaratunga C, Lim P, Suon S, Sreng S, Mao S, Sopha C, et al. Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study. Lancet Infect Dis 2016;16(3):357–65. https://www.ncbi.nlm.nih.gov/pubmed/26774243
Aung NM, Kaung M, Kyi TT, Kyaw MP, Min M, Htet ZW, et al. The safety of a conservative fluid replacement strategy in adults hospitalised with malaria. PLoS One 2015;10(11):e0143062. https://www.ncbi.nlm.nih.gov/pubmed/26581060
Ballard SB, Salinger A, Arguin PM, Desai M, Tan KR. Updated CDC recommendations for using artemether-lumefantrine for the treatment of uncomplicated malaria in pregnant women in the United States. MMWR Morb Mortal Wkly Rep 2018;67(14):424–31. https://www.ncbi.nlm.nih.gov/pubmed/29649190
Barber BE, Grigg MJ, William T, Yeo TW, Anstey NM. The treatment of Plasmodium knowlesi malaria. Trends Parasitol 2017;33(3):242–53. https://www.ncbi.nlm.nih.gov/pubmed/27707609
Chavada R, Hui SH, O'Connor S, Akima S, Gosbell IB. Post-artesunate delayed haemolysis in severe imported Plasmodium falciparum malaria. Med J Aust 2015;203(9):364. https://www.ncbi.nlm.nih.gov/pubmed/26510804
Commons RJ, McCarthy JS, Price RN. Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency. Med J Aust 2020;212(4):152-3 e1. https://www.ncbi.nlm.nih.gov/pubmed/32036613
Dellicour S, Sevene E, McGready R, Tinto H, Mosha D, Manyando C, et al. First-trimester artemisinin derivatives and quinine treatments and the risk of adverse pregnancy outcomes in Africa and Asia: A meta-analysis of observational studies. PLoS Med 2017;14(5):e1002290. https://www.ncbi.nlm.nih.gov/pubmed/28463996
Eick-Cost AA, Hu Z, Rohrbeck P, Clark LL. Neuropsychiatric outcomes after mefloquine exposure among U.S. Military service members. Am J Trop Med Hyg 2017;96(1):159–66. https://www.ncbi.nlm.nih.gov/pubmed/28077744
Grigg MJ, William T, Menon J, Dhanaraj P, Barber BE, Wilkes CS, et al. Artesunate-mefloquine versus chloroquine for treatment of uncomplicated Plasmodium knowlesi malaria in Malaysia (ACT KNOW): an open-label, randomised controlled trial. Lancet Infect Dis 2016;16(2):180–8. https://www.ncbi.nlm.nih.gov/pubmed/26603174
Hanson J, Anstey NM, Bihari D, White NJ, Day NP, Dondorp AM. The fluid management of adults with severe malaria. Crit Care 2014;18(6):642. https://www.ncbi.nlm.nih.gov/pubmed/25629462
Hemming-Schroeder E, Lo E. Evidence of a hard selective sweep for artemisinin resistant Plasmodium falciparum. Lancet Infect Dis 2017;17(5):462–3. https://www.ncbi.nlm.nih.gov/pubmed/28161568
Imwong M, Suwannasin K, Kunasol C, Sutawong K, Mayxay M, Rekol H, et al. The spread of artemisinin-resistant Plasmodium falciparum in the Greater Mekong subregion: a molecular epidemiology observational study. Lancet Infect Dis 2017;17(5):491–7. https://www.ncbi.nlm.nih.gov/pubmed/28161569
Kakuru A, Jagannathan P, Muhindo MK, Natureeba P, Awori P, Nakalembe M, et al. Dihydroartemisinin-piperaquine for the prevention of malaria in pregnancy. N Engl J Med 2016;374(10):928–39. https://www.ncbi.nlm.nih.gov/pubmed/26962728
Llanos-Cuentas A, Lacerda MV, Rueangweerayut R, Krudsood S, Gupta SK, Kochar SK, et al. Tafenoquine plus chloroquine for the treatment and relapse prevention of Plasmodium vivax malaria (DETECTIVE): a multicentre, double-blind, randomised, phase 2b dose-selection study. Lancet 2014;383(9922):1049–58. https://www.ncbi.nlm.nih.gov/pubmed/24360369
Moore KA, Simpson JA, Paw MK, Pimanpanarak M, Wiladphaingern J, Rijken MJ, et al. Safety of artemisinins in first trimester of prospectively followed pregnancies: an observational study. Lancet Infect Dis 2016;16(5):576–83. https://www.ncbi.nlm.nih.gov/pubmed/26869377
Nyein PP, Aung NM, Kyi TT, Htet ZW, Anstey NM, Kyi MM, et al. High frequency of clinically significant bacteremia in adults hospitalized with falciparum malaria. Open Forum Infect Dis 2016;3(1):ofw028. https://www.ncbi.nlm.nih.gov/pubmed/26989752
Phyo AP, Win KK, Thu AM, Swe LL, Htike H, Beau C, et al. Poor response to artesunate treatment in two patients with severe malaria on the Thai-Myanmar border. Malar J 2018;17(1):30. https://www.ncbi.nlm.nih.gov/pubmed/29334942
Plewes K, Kingston HWF, Ghose A, Wattanakul T, Hassan MMU, Haider MS, et al. Acetaminophen as a renoprotective adjunctive treatment in patients with severe and moderately severe falciparum malaria: A randomized, controlled, open-label trial. Clin Infect Dis 2018. https://www.ncbi.nlm.nih.gov/pubmed/29538635
Pregact Study Group, Pekyi D, Ampromfi AA, Tinto H, Traore-Coulibaly M, Tahita MC, et al. Four artemisinin-based treatments in african pregnant women with malaria. N Engl J Med 2016;374(10):913–27. https://www.ncbi.nlm.nih.gov/pubmed/26962727
Price RN, Seidlein L, Valecha N, Nosten F, Baird JK, White NJ. Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis. Lancet Infect Dis 2014;14(10):982–91. https://www.ncbi.nlm.nih.gov/pubmed/25213732
Rutledge GG, Marr I, Huang GKL, Auburn S, Marfurt J, Sanders M, et al. Genomic characterization of recrudescent Plasmodium malariae after treatment with artemether/lumefantrine. Emerg Infect Dis 2017;23(8):1300–7. https://www.ncbi.nlm.nih.gov/pubmed/28430103
Spring MD, Lin JT, Manning JE, Vanachayangkul P, Somethy S, Bun R, et al. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study. Lancet Infect Dis 2015;15(6):683–91. https://www.ncbi.nlm.nih.gov/pubmed/25877962
Tun KM, Imwong M, Lwin KM, Win AA, Hlaing TM, Hlaing T, et al. Spread of artemisinin-resistant Plasmodium falciparum in Myanmar: a cross-sectional survey of the K13 molecular marker. Lancet Infect Dis 2015;15(4):415–21. https://www.ncbi.nlm.nih.gov/pubmed/25704894
